Cited by 125Traumatic Brain Injury ResearchTraumatic Brain Injury and Neurovascular DisturbancesPosttraumatic Stress Disorder Research

Depression Following Traumatic Brain Injury: Epidemiology, Risk Factors and Management

Rapoport, Mark J.·2012·CNS Drugs

Abstract

It is important for clinicians to recognize major depression following traumatic brain injury (TBI) because of its association with poor global and psychosocial outcome, postconcussive symptoms and cognitive deficits. The purpose of this review is to provide an up-to-date selective review of the current understanding of epidemiology, risk factors and management of major depression following TBI. Many studies of prevalence of depression following TBI have not used accepted structured criteria for the diagnoses, but those that did found wide ranges of rates, from 17% to 61%. The risk factors for development of depression following TBI are poorly understood, but past psychiatric history, frontal lesions and atrophy, and family dysfunction have been shown in more than one study to play important roles. There are few controlled trials of the treatment of major depression in patients with TBI using accepted diagnostic criteria for major depression, as well as defined criteria for response and remission. As such, it is important for clinicians to use best practice guidelines for the treatment of major depression in the absence of TBI.

Integrity signals

Registry

Crossref · 10.2165/11599560-000000000-00000

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rapoport, M. J.
Affiliations
Sunnybrook Health Science Centre (CA)
Corresponding author
Rapoport, Mark J.
Venue
CNS Drugs
Published
2012-02
Volume
26
Issue
2
Pages
111-121
ISSN
1172-7047 (ISSN-L)
OpenAlex
W2035993893
Cited by
125
References
76
Citations by year
2026: 2 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 30 · 2020: 3 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 6 · 2015: 13 · 2014: 14 · 2013: 11
FWCI
9.07
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
Keywords
major depressive disorder, traumatic brain injury, post-traumatic depression, depression prevalence, risk factors, frontal lobe lesions, brain atrophy, family dysfunction, post-concussion symptoms, cognitive impairment, depression treatment, psychosocial outcomes
MeSH terms
Brain Injuries, Depressive Disorder, Humans, Psychiatric Status Rating Scales, Risk Factors, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review